TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/13/2024
Back to search
Official data from USPTO
IMMUDEX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
11/19/2024
Trademark type
Combined
Nice classes
1, 5, 42
Filing date
12/10/2021
Registration date
01/23/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/23/2024
Last transaction
11/19/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
DK
Examiner
ALLEN, BIANCA LEIGH
Law office
N50
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "IMMUDEX" wherein the letters are colored blue, and the dot of the letter "I" is colored orange.
Holders and representatives
Holders
I. A. (pessoa física)
Representatives
Miriam D. Trudell Davis Graham & Stubbs LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals used in industry and sciencein the nature of immune related chemicals for immune cell analysisimmune cell monitoringimmune cell detection and immune cell stimulation and immune related chemicals used in science in the nature of MHC monomer and multimer reagentsMR1 monomer and multimer reagentsCD1 monomer and multimer reagentsantibodiesantigen monomer and multimer reagentsreagentsdiagnostic agentscontrol reagentsoligonucleotide conjugated multimer reagents in the nature of DNA/RNA oligo conjugated multimer reagents; diagnostic reagents for diagnostic being research useother than medical and veterinary usescientific use; research diagnostic reagents for scientific use; diagnostic test materials for scientific and diagnosticother than medical and veterinarypurposesdiagnostic reagents and preparationsexcept for medical or veterinary use; diagnostic kits for scientific and diagnosticother than medical and veterinarypurposes comprised of diagnostic reagents and preparationsexcept for medical or veterinary use and also comprised of immune related chemicals used in sciencein the nature of MHC monomer and multimer reagentsMR1 monomer and multimer reagentsCD1 monomer and multimer reagentsantibodiesantigen monomer and multimer reagentsreagentsdiagnostic agentscontrol reagentsoligonucleotide conjugated multimer reagents in the nature of DNA/RNA oligo conjugated multimer reagents; assays for research purposes; biochemical reagents for non- medical purposesother than medical and veterinary; chemical and diagnostic preparations for analysis for research purposes related to vaccines and immunotherapycancer vaccinesborrelia vaccinesTB- vaccinesHIV-vaccinesCMV-vaccines and other vaccinesfor use in scientific research in connection with therapy and immunotherapyin particularfor use in cancer therapycancer immunotherapyfor analysis of T-cell lymphomaT-cell infiltration of solid tumors and tissue; chemicaldiagnostic preparations for analysis for research purposes related to analysis of infectious diseasesautoimmunity and for use in scientific research in connection with toxicological studiestransplantationimmune monitoringvaccines and T-cell monitoring; chemical reagents for other than medicinal and veterinary purposes
Class 5
Preparations for pharmaceutical purposespharmaceutical preparations for the treatment of cancerT-cell lymphomaT-cell infiltration of solid tumors and tissueT-cell diseases in bloodtransplantation related diseases and diseases related to immune suppressionautoimmune disease and infectious diseases; preparations for medical purposesdiagnostic preparations for medical purposes and medical preparations for treatment of cancerT-cell lymphomaT-cell infiltration of solid tumors and tissueT-cell diseases in bloodtransplantation related diseases and diseases related to immune suppressionautoimmune disease and infectious diseases; chemical-pharmaceutical preparations for treatment of cancerT-cell lymphomaT-cell infiltration of solid tumors and tissueT- cell diseases in bloodtransplantation related diseases and diseases related to immune suppressionautoimmune disease and infectious diseases; diagnostic preparations for medical purposes; vaccines; diagnostic preparations for analysis for medical purposeshereunder for each of the abovementioned preparations for medical analysis of vaccinesimmunotherapeutics and cellular therapiesin particular cancer vaccines and immunotherapeuticsborrelia vaccinesTB-vaccinesHIV- vaccines and CMV-vaccinesT-cell therapiesfor use in connection with cancer therapy or other therapyfor medical analysis and treatment of T- cell lymphomaT-cell infiltration of solid tumors and tissuefor infectious diseases; diagnostic preparations for analysis for medical purposeshereunder for use in connection with toxicological studiestransplantationimmune monitoringvaccines and T-cell monitoring
Class 42
Scientific and technological servicesscientific researchanalysis and testing in the fields of medicinepharmaceuticalsthe immune systemmedical diagnostic analysis and vaccines; scientific research; scientific research servicesdiagnostic services related to research; analysis of medicinepharmaceuticals and vaccines of others to assure compliance with industry standards; industrial research services in the fields of medicinepharmaceuticalsthe immune systemmedical diagnostic analysis and vaccines; basic scientific research and clinical scientific researchhereunder for medicine and vaccine development; product research and development in the field of diagnostic preparations
Publications
History of USPTO decisions and trademark events.
39 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/13/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/13/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/13/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/24/2024
FIMP
FINAL DISPOSITION PROCESSED
04/23/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/23/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/23/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
01/23/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/07/2023
PUBO
PUBLISHED FOR OPPOSITION
11/07/2023
GPNX
NOTIFICATION PROCESSED BY IB
11/06/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/18/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
10/18/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/18/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/05/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/04/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/04/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
10/04/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
08/06/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/19/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
07/19/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
07/06/2023
GNFR
FINAL REFUSAL E-MAILED
07/06/2023
CNFR
FINAL REFUSAL WRITTEN
07/06/2023
DOCK
ASSIGNED TO EXAMINER
06/05/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/03/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/27/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/27/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/02/2023
RFNT
REFUSAL PROCESSED BY IB
11/14/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/27/2022
RFRR
REFUSAL PROCESSED BY MPU
10/27/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/02/2022
CNRT
NON-FINAL ACTION WRITTEN
09/01/2022
DOCK
ASSIGNED TO EXAMINER
08/24/2022
MAFR
APPLICATION FILING RECEIPT MAILED
02/26/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/22/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/17/2022
Continuous trademark protection
Get notified about every new filing that threatens IMMUDEX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.